Abstract:Objective: The aim of this study was to investigate the mechanism to reverse the drug resistance of leukemia cells in Cyclosporine A(CsA), tetrandrine (Tet) alone or their combination by using empirical methods, and to provide the basic evidence for further study, and lay the theoretical basis for the clinical applications. Method: By MTT assay, the IC50(the concentration causing 50% inhibitor of cell growth) of DNR was determined;By flow cytomet ry (FCM) assay, the intracellular DNR concentration and the expression of P-glyco-protein (P-gp) were examined, and the apoptotic changes were observed by Anexin-V. By fluorescent semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR), the mRNA expression of multidrug resistance (MDR) was measured. Results: The IC50 of DNR for K562 and K562/A02 cells were 0.26mg/l and 21.22mg/l respectively. Treating K562/A02 cells with CsA(1mg/L), TTD(0.1mg/L)and both for 48 hours partially restored the sensitivity of K562/A02 cells to DNR(IC50 were 7.83 mg/L,5.32 mg/L,2.33 mg/L respectively.) but had not effect on K562 cells; K562/A02 cells showed apoptotic characteristics after treated with CsA, and both for 48 hours(Apoptosis rate was 10.27%,17.64%,52.79% respectively); The fluorescence intensity of intracellelar DNR in K562 and K562/A02 cells treated with DNR(1mg/L)was 522,173 respectively. CsA and TTD (alone or combination) elevated the intracellular DNR concentration in K562/A02 cells(the fluorescence intensity of intracellelar DNR in K562/A02 cells was 188,339,515 respectively); The fluorescence intensity of P-gp in K562 and K562/A02 cells was 0.5,97.97. The P-gp expression was down after treated with CsA, TTD and both(73.7,65.05,58.1); mdr1 mRNA was also down regulated, and the effect of their combination was greater. Date was analyzed by SPSS 13.0 software and expressed as mean ± SD. Conclusions: High expression of P-gp may be involved in the mechanism of multidrug resistance (MDR) of K562/A02 cells line; MDR can be partially reversed by CsA or TTD, of which the combination shows a great synergistic reversal effect.

Synthesis and Antimultidrug Resistance Evaluation of Icariin and Its Derivatives

Synthesis and antibacterial activity of novel icariin derivatives.

Synthesis, Pharmacological Activity of a Series of Genistein Derivatives as Modulators of Multidrug Resistance

Artemisinin-indole and Artemisinin-Imidazole Hybrids: Synthesis, Cytotoxic Evaluation and Reversal Effects on Multidrug Resistance in MCF-7/ADR Cells.

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Synthesis and Primary Evaluation of Quinoxalinone Derivatives As Potent Modulators of Multidrug Resistance

Design, Synthesis and Biological Evaluation of Biaryl Amide Derivatives As Modulators of Multi-Drug Resistance

Synthesis and Evaluation of Substituted Dibenzo[c,e]azepine-5-ones As P-glycoprotein-mediated Multidrug Resistance Reversal Agents

Synthesis and Multidrug Resistance Reversal Activity of 1-Akyl-2-acetyl-1,2,3, 4-Tetrahydroisoquinoline Derivatives

Discovery to Solve Multidrug Resistance: Design, Synthesis, and Biological Evaluation of Novel Agents

In Vitro Study of the Effect of Cyclosporine A, Tetrandrine and Their Combination on the Reversion of Multidrug Resistance in Leukemia Cell Line.

1-Benzyl-1,2,3,4-tetrahydroisoquinoline Derivatives and Optically Pure Isomers As Novel Promising Multidrug Resistance (mdr) Reversing Agents

Synthesis of A Novel Series of (E,e)-4,6-bis(styryl)-2-o-glucopyranosyl-pyrimidines and Their Potent Multidrug Resistance (mdr) Reversal Activity Against Cancer Cells

Design, Synthesis and Biological Evaluation of Novel Tetrahydroisoquinoline Derivatives As P-glycoprotein-mediated Multidrug Resistance Inhibitors.

Screening Novel, Potent Multidrug-Resistant Modulators from Imidazole Derivatives

Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms.

Synthesis and multidrug resistance reversal activity of dihydroptychantol A and its novel derivatives.

Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell

Design, Synthesis and Biological Evaluation of LBM-A5 Derivatives As Potent P-glycoprotein-mediated Multidrug Resistance Inhibitors.

Design, Synthesis and Biological Evaluation of Novel Triazole-Core Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance

Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[ h ]chromen-4-one conjugates as dual ABCB1/CYP1B1 inhibitors for overcoming MDR in cancer